test Browse by Author Names Browse by Titles of Works Browse by Subjects of Works Browse by Issue Dates of Works
       

Advanced Search
Home   
 
Browse   
Communities
& Collections
  
Issue Date   
Author   
Title   
Subject   
 
Sign on to:   
Receive email
updates
  
My Account
authorized users
  
Edit Profile   
 
Help   
About T-Space   

T-Space at The University of Toronto Libraries >
University of Toronto at Scarborough >
Bioline International Legacy Collection >
Bioline International Legacy Collection >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1807/5428

Title: Brief Communication - T2 weighted MRI in assessment of volume changes during radiotherapy of high grade gliomas
Authors: Shukla, Divya
Huilgol, Nagraj G.
Trivedi, Naresh
Mekala, C.
Keywords: Radiotherapy, High grade gliomas, Tumor volumes
Issue Date: 31-Dec-2005
Publisher: Medknow Publications on behalf of the Association of Radiation Oncologists of India (AROI)
Citation: Journal of Cancer Research and Therapeutics (ISSN: 0973-1482) Vol 1 Num 4
Abstract: Aim: To determine whether any changes in gross tumor volume occur between pre treatment MRI and week 5 MRI in high grade gliomas treated by conformal radiotherapy. Methods and Materials: Between july 2003-july 2005, 17 patients with WHO grades 3 and 4 malignant gliomas treated with conformal radiotherapy to a total dose of 60 Gy were included in this retrospective study. All patients had undergone T2 weighted MRI a day before treatment and then again at end of week 5 of treatment for definition of initial and boost fields respectively. Gross tumor volumes were delineated on the two MRI′s of each patient and the differences were noted. Two patients with multifocal disease were excluded from the final analysis. Results: Of the 15 patients with unifocal disease, 12/15 cases (80%) showed a reduction in tumor volumes (median 54.85 cc). Of these, 4/15(26.6%) cases (two each of grade 3 and grade 4 gliomas) had an objective reduction in GTV (>=50%) and 3/15(20%) cases (two of grade 4 and one of grade 3 gliomas) demonstrated an increase in tumor volume (median 14 cc). Conclusions: This study has shown that a change in gross tumor volume occurred in almost all patients on week 5 MRI. The likelihood of treatment success would appear to be decreased if the tumour is not within the treatment field and hence it may be worthwhile to do a mid treatment MRI for definition of boost volumes especially in dose escalation trials employing highly conformal radiotherapy fields.
URI: http://hdl.handle.net/1807/5428
Other Identifiers: http://www.bioline.org.br/abstract?id=cr05050
Rights: Copyright 2005 Journal of Cancer Research and Therapeutics.
Appears in Collections:Bioline International Legacy Collection

Files in This Item:

File Description SizeFormat
cr05050.pdf100.28 kBAdobe PDF
View/Open

Items in T-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

uoft